Literature DB >> 19948717

The linker for activation of B cells (LAB)/non-T cell activation linker (NTAL) regulates triggering receptor expressed on myeloid cells (TREM)-2 signaling and macrophage inflammatory responses independently of the linker for activation of T cells.

Gillian C Whittaker1, Selinda J Orr, Laura Quigley, Laurel Hughes, Ivo M B Francischetti, Weigou Zhang, Daniel W McVicar.   

Abstract

Triggering receptor expressed on myeloid cells-2 (TREM-2) is rapidly emerging as a key regulator of the innate immune response via its regulation of macrophage inflammatory responses. Here we demonstrate that proximal TREM-2 signaling parallels other DAP12-based receptor systems in its use of Syk and Src-family kinases. However, we find that the linker for activation of T cells (LAT) is severely reduced as monocytes differentiate into macrophages and that TREM-2 exclusively uses the linker for activation of B cells (LAB encoded by the gene Lat2(-/-)) to mediate downstream signaling. LAB is required for TREM-2-mediated activation of Erk1/2 and dampens proximal TREM-2 signals through a novel LAT-independent mechanism resulting in macrophages with proinflammatory properties. Thus, Lat2(-/-) macrophages have increased TREM-2-induced proximal phosphorylation, and lipopolysaccharide stimulation of these cells leads to increased interleukin-10 (IL-10) and decreased IL-12p40 production relative to wild type cells. Together these data identify LAB as a critical, LAT-independent regulator of TREM-2 signaling and macrophage development capable of controlling subsequent inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948717      PMCID: PMC2823438          DOI: 10.1074/jbc.M109.038398

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Non-T cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells.

Authors:  Anja S Tessarz; Sandra Weiler; Kai Zanzinger; Pavla Angelisová; Václav Horejsí; Adelheid Cerwenka
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

2.  Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12.

Authors:  Jessica A Hamerman; Jessica R Jarjoura; Mary Beth Humphrey; Mary C Nakamura; William E Seaman; Lewis L Lanier
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

3.  Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis.

Authors:  Laura Piccio; Cecilia Buonsanti; Margherita Mariani; Marina Cella; Susan Gilfillan; Anne H Cross; Marco Colonna; Paola Panina-Bordignon
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

4.  Cutting edge: TREM-2 attenuates macrophage activation.

Authors:  Isaiah R Turnbull; Susan Gilfillan; Marina Cella; Taiki Aoshi; Mark Miller; Laura Piccio; Maristela Hernandez; Marco Colonna
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

5.  ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus.

Authors:  Mark Lucas; Xia Zhang; Vikram Prasanna; David M Mosser
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

6.  Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45.

Authors:  Llewellyn H Mason; Jami Willette-Brown; Lynn S Taylor; Daniel W McVicar
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

7.  TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases.

Authors:  Mirjam Schenk; Axel Bouchon; Frank Seibold; Christoph Mueller
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

8.  Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation.

Authors:  Laura Piccio; Cecilia Buonsanti; Marina Cella; Ilaria Tassi; Robert E Schmidt; Chiara Fenoglio; John Rinker; Robert T Naismith; Paola Panina-Bordignon; Nadia Passini; Daniela Galimberti; Elio Scarpini; Marco Colonna; Anne H Cross
Journal:  Brain       Date:  2008-09-12       Impact factor: 13.501

9.  TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.

Authors:  Kazuya Takahashi; Marco Prinz; Massimiliano Stagi; Olga Chechneva; Harald Neumann
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

10.  DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis.

Authors:  Isaiah R Turnbull; Jonathan E McDunn; Toshiyuki Takai; R Reid Townsend; J Perren Cobb; Marco Colonna
Journal:  J Exp Med       Date:  2005-08-01       Impact factor: 14.307

View more
  19 in total

1.  Tyrosine phosphorylation-independent regulation of lipopolysaccharide-mediated response by the transmembrane adaptor protein LAB.

Authors:  Minghua Zhu; Deirdre M Fuller; Chih-wen Ou-Yang; Sarah A Sullivan; Weiguo Zhang
Journal:  J Immunol       Date:  2012-02-03       Impact factor: 5.422

Review 2.  LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes?

Authors:  Selinda J Orr; Daniel W McVicar
Journal:  J Leukoc Biol       Date:  2010-07-19       Impact factor: 4.962

3.  Environmental factors determine DAP12 deficiency to either enhance or suppress immunopathogenic processes.

Authors:  Vanessa Montalvo; Laura Quigley; Barbara P Vistica; Kimberly C Boelte; Lindsey F Nugent; Toshiyuki Takai; Daniel W McVicar; Igal Gery
Journal:  Immunology       Date:  2013-12       Impact factor: 7.397

Review 4.  A tale of two TRAPs: LAT and LAB in the regulation of lymphocyte development, activation, and autoimmunity.

Authors:  Deirdre M Fuller; Minghua Zhu; Chih-Wen Ou-Yang; Sarah A Sullivan; Weiguo Zhang
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

5.  Mammary gland morphological and gene expression changes underlying pregnancy protection of breast cancer tumorigenesis.

Authors:  Yogi Misra; Pamela A Bentley; Jeffrey P Bond; Scott Tighe; Timothy Hunter; Feng-Qi Zhao
Journal:  Physiol Genomics       Date:  2011-11-15       Impact factor: 3.107

6.  TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release.

Authors:  Daniel Smrz; Shoko Iwaki; Daniel W McVicar; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Eur J Immunol       Date:  2010-11-11       Impact factor: 5.532

Review 7.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

8.  Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.

Authors:  Jian Zhou; Weihua Yu; Man Zhang; Xin Tian; Yu Li; Yang Lü
Journal:  Neurochem Res       Date:  2019-02-12       Impact factor: 3.996

Review 9.  The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis.

Authors:  Marco Genua; Sergio Rutella; Carmen Correale; Silvio Danese
Journal:  J Transl Med       Date:  2014-10-28       Impact factor: 5.531

10.  LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-γ production by repressing β-catenin activation in dendritic cells.

Authors:  Selinda J Orr; Ashley R Burg; Tim Chan; Laura Quigley; Gareth W Jones; Jill W Ford; Deborah Hodge; Catherine Razzook; Joseph Sarhan; Yava L Jones; Gillian C Whittaker; Kimberly C Boelte; Lyudmila Lyakh; Marco Cardone; Geraldine M O'Connor; Cuiyan Tan; Hongchuan Li; Stephen K Anderson; Simon A Jones; Weiguo Zhang; Philip R Taylor; Giorgio Trinchieri; Daniel W McVicar
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.